Comparison of the effects of sitagliptin and mitiglinide/voglibose fixed-dose combination tablets on glucose metabolism in patients with uncontrolled type-2 diabetes mellitus. - Comparison of the effects of sitagliptin and mitiglinide/voglibose fixed-dose combination tablets on glucose metabolism

niversity of Occupational and Environmental Health, Japan0 个研究点目标入组 5 人开始时间: 2012年6月27日最近更新: 2023年10月17日

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 5

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

Increasing the dose of STG to 100 mg/day reduces blood glucose levels from midnight to early morning in patients with postprandial hyperglycemia who have HbA1c values of approximately 7%, FPG levels of approximately 120 mg/dL, and postprandial glucose levels >200 mg/dL. In addition, switching to MIT/VOG improves fluctuations in blood glucose levels and postprandial hyperglycemia.

研究设计

研究类型: Interventional

入排标准

年龄范围: 20years-old 至 ot applicable（—）
性别: All

入选标准

未提供

排除标准

•1) Patients treated with a sulfonylurea (SU), alfa-glycosidase inhibitor (alfa-GI) or insulin secretagogue (glinide). 2) Patients with diabetic ketoacidosis, diabetic coma/precoma or type-1 diabetes mellitus. 3) Patients with severe infection or serious trauma, or those operated recently or scheduled for surgery. 4) Patients with moderate or severer renal disorder (creatinine level 1.5 mg/dL (men) or 1.3 mg/dL (women)). 5) Patients with liver disorder (AST or ALT level 3 times the normal upper limit). 6) Women who are pregnant or suspected of being pregnant. 7) Women who are breastfeeding. 8) Patients with a history of hypersensitivity to an ingredient of the study drugs. 9) Other patients judged to be ineligible by the investigator.

研究者

发起方

niversity of Occupational and Environmental Health, Japan

相似试验

已完成

不适用

Effects of sitagliptin on daily glucose fluctuation in Japanese type 2 diabetic outpatients inadequately controlled with insulin therapy

JPRN-UMIN000012735Aichi Medical University Division of Diabetes, Department of Internal Medicine, Diabetes Center30

已完成

4 期

Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and SulfonylureaType 2 Diabetes

NCT01195090Sung-Chen Liu120

Unknown

2 期

Effect of Sitagliptin in Impaired Glucose ToleranceImpaired Glucose Tolerance

NCT00961363National Taiwan University Hospital60

撤回

不适用

Sitagliptin in Type I Diabetic PatientsDiabetes Type I

NCT01741103University at Buffalo

已完成

不适用

Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid TherapyPre-diabetesImpaired Fasting GlucoseImpaired Glucose Tolerance

NCT01488279University of Vermont10